NCT06772194 · RECRUITING

Taiwan Post-Stroke Disability Study

This is an observational study, not a treatment trial. Researchers in Taiwan are enrolling 2,000 stroke patients and following them for one year to track disabilities that develop after stroke — including memory problems, depression, swallowing difficulties, and seizures. There is no drug or intervention being tested. The goal is to better understand how common these problems are and what risk factors drive them. No phase is assigned because no treatment is being evaluated.

You may qualify if

  • Ischemic stroke confirmed by MRI, or hemorrhagic stroke diagnosed by CT or MRI.
  • Age ≥ 18 years.
  • Pre-stroke modified Rankin Scale (mRS) score of 0, 1, or 2.
  • Post-stroke mRS score of 0, 1, 2, 3, or 4 at enrollment.
  • Able to undergo cognitive function screening and other scale assessments within 30 days post-stroke.

You're excluded if

  • Transient ischemic stroke and subarachnoid hemorrhage.
  • Clear and severe psychiatric or emotional disorders before the stroke, including schizophrenia, major depressive disorder, and bipolar disorder.
  • History of clinical stroke within three months prior to enrollment.
  • Unable to communicate or cooperate for assessments due to severe aphasia.
  • Severe dementia prior to the stroke.
  • Pre-stroke modified Rankin Scale (mRS) score ≥ 3.
  • Post-stroke mRS score of 5 at enrollment.
  • History of cancer with an expected life expectancy of less than one year.
  • Expected life expectancy of less than one year due to other medical conditions.
  • Anticipated inability to complete a one-year follow-up.
  • Other situations deemed unsuitable for enrollment by the clinical investigator.

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2025-05-13

View full record on ClinicalTrials.gov

All APOE4 clinical trials